Dr. Keyzner’s clinical and research focus is on the use and optimization of allogeneic stem cell transplant for the management of patients with myeloid malignancies. She is the site principal investigator for numerous multi-center clinical trials studying new therapeutic approaches for acute myeloid leukemia and cord blood transplantation.
Subscribe to the weekly "HealthTree Community for AML Newsletter" for AML news, life with AML stories, AML clinical trials, AML 101 articles and events with AML experts.
Terms of Use and Privacy Policy Newsroom About Donations Find an AML Specialist Newsletter Learn Connect
Copyright © 2022 HealthTree Foundation. All Rights Reserved.
The HealthTree Foundation / HealthTree for AML is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811